![Paul Perreault](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Perreault
Vorstandsvorsitzender bei
CSL Behring AB
Profil
Derzeit ist Paul Roger Perreault Chief Executive Officer, Executive Director & MD bei CSL Ltd. In seiner bisherigen Laufbahn hatte er die Position des Chairman-Global Board bei der Plasma Protein Therapeutics Association, Chief Executive Officer & Managing Director bei CSL Behring LLC, Vice President & General Manager bei Aventis Behring, Business Director bei Wyeth-Ayerst Research und Vice President & General Manager bei Aventis Bio-Services, Inc. Herr Perreault erwarb einen Bachelor-Abschluss an der University of Central Florida.
Aktive Positionen von Paul Perreault
| Unternehmen | Position | Beginn |
|---|---|---|
CSL Behring AB
 CSL Behring AB Pharmaceuticals: MajorHealth Technology Develops and delivers therapies that are used to treat coagulation disorders, primary immune deficiencies, hereditary angioedema, inherited respiratory disease and neurological disorders | Vorstandsvorsitzender | - |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Direktor/Vorstandsmitglied | 01.12.2020 |
CSL Finance Plc
 CSL Finance Plc Finance/Rental/LeasingFinance Functions as a financing subsidiary/special purpose entity | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Paul Perreault
| Unternehmen | Position | Ende |
|---|---|---|
| CSL LIMITED | Vorstandsvorsitzender | 06.03.2023 |
Plasma Protein Therapeutics Association
 Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services Non-profit organization representing manufacturers and plasma collection centers | Vorsitzender | - |
Aventis Behring
 Aventis Behring Pharmaceuticals: MajorHealth Technology Develops pharmaceutical and agricultural products | Corporate Officer/Principal | - |
Aventis Bio-Services, Inc.
 Aventis Bio-Services, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical and agricultural products | Corporate Officer/Principal | - |
Wyeth-Ayerst Research | Corporate Officer/Principal | - |
Ausbildung von Paul Perreault
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
62
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Plasma Protein Therapeutics Association
Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services Non-profit organization representing manufacturers and plasma collection centers | Commercial Services |
Aventis Bio-Services, Inc.
Aventis Bio-Services, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical and agricultural products | Health Technology |
Aventis Behring
Aventis Behring Pharmaceuticals: MajorHealth Technology Develops pharmaceutical and agricultural products | Health Technology |
University of Central Florida
 University of Central Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Health Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Wyeth-Ayerst Research | |
CSL Behring AB
CSL Behring AB Pharmaceuticals: MajorHealth Technology Develops and delivers therapies that are used to treat coagulation disorders, primary immune deficiencies, hereditary angioedema, inherited respiratory disease and neurological disorders | Health Technology |
CSL Finance Plc
CSL Finance Plc Finance/Rental/LeasingFinance Functions as a financing subsidiary/special purpose entity | Finance |
